Decheng Capital »

Arcus Biosciences Incorporated shares owned by Decheng Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Decheng Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 870k 19.10

More positions owned by Decheng Capital

Alpine Immune Sciences (ALPN)
Zentalis Pharmaceuticals (ZNTL)
Pacific Biosciences of California (PACB)
10x Genomics Cl A Com (TXG)
ImmunoGen
Arcus Biosciences Incorporated (RCUS)
Karuna Therapeutics Ord
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Illumina (ILMN)
Argenx SE SHS (ARGX)
Acelyrin (SLRN)
Krystal Biotech (KRYS)
Phathom Pharmaceuticals (PHAT)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Terns Pharmaceuticals (TERN)

View all positions for Decheng Capital

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated